BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3162290)

  • 21. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.
    Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S
    Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
    Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
    J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.
    Lindmark G; Kressner U; Bergström R; Glimelius B
    Anticancer Res; 1996; 16(2):895-8. PubMed ID: 8687147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preoperative determination of serum immunoglobulins in colorectal cancer: correlation between staging and course of the disease].
    Secco GB; Frassetto GL; Venturini M; Santi F; Fardelli R; Terrizzi A
    Minerva Dietol Gastroenterol; 1986; 32(2):183-6. PubMed ID: 3736967
    [No Abstract]   [Full Text] [Related]  

  • 26. [The value and limitations of carcinoembryonic antigen levels (CEA) in colorectal cancers (author's transl)].
    Grossetti D; de Certaines J; Trebuchet G; Auvray E; Bernard AM; Launois B
    Ann Chir; 1981 Dec; 35(10):875-7. PubMed ID: 7325563
    [No Abstract]   [Full Text] [Related]  

  • 27. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
    Muhrer KH; Schwemmle K; Filler D; Kahle M
    Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of carcinoembryonic antigen in the monitoring of colorectal cancer].
    Lagache G
    Verh K Acad Geneeskd Belg; 1980; 42(1):60-73. PubMed ID: 7445709
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate antigens and liver metastasis in colorectal cancer.
    Hasegawa H; Watanabe M; Arisawa Y; Teramoto T; Kodaira S; Kitajima M
    Jpn J Clin Oncol; 1993 Dec; 23(6):336-41. PubMed ID: 7904324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological aspects of colorectal cancer.
    Sjögren HO
    Clin Gastroenterol; 1976 Sep; 5(3):563-71. PubMed ID: 1032988
    [No Abstract]   [Full Text] [Related]  

  • 34. [Follow-up of colorectal neoplasms: use of TPA].
    Citone G; Catani M; Procacciante F; Perri S; Pronio A; Ribotta G
    Minerva Chir; 1987 Oct; 42(20):1625-6. PubMed ID: 3683924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Follow-ups after colorectal cancer].
    Wählby L
    Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2541. PubMed ID: 9667137
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prognostic significance of preoperative CEA titers in colorectal cancer].
    Schneider K; Metzger U; Joller H; Grob PJ; Largiadèr F
    Helv Chir Acta; 1983 Mar; 49(6):843-7. PubMed ID: 6862990
    [No Abstract]   [Full Text] [Related]  

  • 37. Surgery for colon and rectal cancer.
    Mitry E; Barthod F; Penna C; Nordlinger B
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):253-65. PubMed ID: 11969237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors in colorectal cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2202-8. PubMed ID: 3408254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preoperative determination of TPA in colorectal neoplasms. Evaluation of a group consisting of 75 patients].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jul; 42(13-14):1181-4. PubMed ID: 3670651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.